Pediatrics | Eklavya Medical
child_care
medical_services Main Specialty Domain lock Subscription Required

Pediatrics

Child health, neonatal care, pediatric resuscitation, and developmental milestone diagnostics.

verified Verified Medical Faculty menu_book 271 Q&A Modules
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 181 person Asked by .
bookmark_add

Retinoblastoma

description Clinical Response
Q138 · DNB/MD 2014/1
Retinoblastoma
Examiner's Intent: Expects the classic Knudson two-hit hypothesis (a foundational cancer genetics concept for which retinoblastoma is the prototype), the leukocoria differential diagnosis, and awareness of contemporary eye-preserving treatment approaches.

Genetics — RB1 Gene and Knudson's Two-Hit Hypothesis

TypeProportionMechanismPresentation
Hereditary~40%First hit inherited (present in every cell) + one somatic second hit neededEarlier presentation; frequently bilateral/multifocal
Sporadic~60%Both hits must occur somatically in the same single retinal cell (statistically much less likely)Later presentation; near-exclusively unilateral, unifocal

[Diagram: Knudson two-hit hypothesis diagram: hereditary (germline first hit + single somatic second hit) vs sporadic (both hits somatic in one cell)]

Clinical Presentation — Leukocoria and its Differential Diagnosis

Leukocoria (abnormal white pupillary reflex) is the most common presenting sign. Differential diagnosis:

  • Congenital cataract
  • Persistent Fetal Vasculature (formerly PHPV)
  • Coats disease
  • Retinopathy of prematurity (Section 1, Q8)
  • Ocular toxocariasis

International Classification of Intraocular Retinoblastoma (ICIR/IIRC)

Groups A–E (increasing severity) — guides eye-preserving vs enucleation decision; Group E generally requires enucleation.

Eye-Preserving Therapies

TherapyDescription
Systemic chemotherapy (“chemoreduction”)Shrinks tumor to allow subsequent limited, eye-preserving local control
Intra-arterial chemotherapyDirect ophthalmic artery catheterization — high local concentration, minimized systemic exposure; relatively recent advance
Laser photocoagulation/cryotherapyFor smaller, peripheral/accessible tumors
Plaque brachytherapyLocalized radioactive plaque over the tumor
Note: Enucleation is reserved for extensive disease not amenable to eye-preserving approaches, or treatment failure — oncological control always takes precedence over eye/vision preservation when the two are in tension.
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 182 person Asked by .
bookmark_add

Pediatric Bone Marrow Transplantation (HSCT)

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q139 · DNB/MD 2011/2
Pediatric Bone Marrow Transplantation (HSCT)
Examiner's Intent: Expects a broad overview of HSCT indications across both malignant and non-malignant conditions, donor selection principles, and awareness of graft-versus-host disease as the central, defining complication.

Indications

CategoryExamples
MalignantHigh-risk/relapsed ALL (Q122); high-risk neuroblastoma (autologous, Q128); other selected malignancies
Non-malignantSevere aplastic anemia (Q123); thalassemia major (Q124); sickle cell disease (increasingly, matched sibling donor); Fanconi anemia and other inherited BMF syndromes; primary immunodeficiency disorders

Donor Selection — HLA Typing

Guided by HLA matching, in descending order of typical preference:

  1. Matched sibling donor — traditional gold standard, best outcomes
  2. Matched unrelated donor — via international registries, generally somewhat inferior to sibling
  3. Umbilical cord blood — rapid availability, greater HLA mismatch tolerance, but smaller stem cell dose
  4. Haploidentical (half-matched) donor — typically a parent; near-universal availability; modern post-transplant cyclophosphamide-based techniques have substantially improved outcomes

Conditioning Regimens

Serve dual purposes: myeloablation (eliminate diseased marrow) and immunosuppression (prevent graft rejection). Reduced-intensity required for Fanconi anemia (Q123). Autologous HSCT avoids GVHD entirely but lacks graft-versus-tumor effect.

Graft-versus-Host Disease (GVHD)

TypeTimingFeaturesManagement
Acute GVHDTypically within first 100 daysSkin, GI tract, liverCorticosteroids and other immunosuppressives
Chronic GVHDLaterBroader, autoimmune/connective-tissue-disease-like presentationProlonged immunosuppressive management

Prevention: calcineurin inhibitor-based prophylaxis; post-transplant cyclophosphamide (especially haploidentical transplant).

lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 183 person Asked by .
bookmark_add

Central Nervous System Tumors in Children

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q140 · DNB/MD 2006/1
Central Nervous System Tumors in Children
Examiner's Intent: Expects awareness that pediatric brain tumors follow a distinctly different anatomical distribution pattern than adult brain tumors, knowledge of the major tumor types, and recognition of raised ICP red flag signs.

Classification and Distinctive Pediatric Distribution Pattern

Key Distinguishing Point: Most adult primary brain tumors are supratentorial; most pediatric brain tumors, especially in younger children, are INFRATENTORIAL (posterior fossa — cerebellum and brainstem) — explains early hydrocephalus (proximity to 4th ventricle/aqueduct) and cerebellar/brainstem symptoms as prominent early features.

[Diagram: Sagittal brain diagram highlighting posterior fossa/infratentorial region as the predominant site of pediatric brain tumors vs supratentorial predominance in adults]
TumorOrigin/LocationKey Features
MedulloblastomaCerebellum (classically vermis in younger children)Most common malignant pediatric brain tumor; CSF-borne “drop metastases” — requires full neuraxis imaging + CSF cytology; craniospinal RT for higher-risk disease
AstrocytomaCerebellum or optic pathway/hypothalamic region (low-grade, e.g. pilocytic); can be higher-gradePilocytic astrocytoma is the most common pediatric brain tumor overall (benign+malignant combined); excellent prognosis with resection
EpendymomaEpendymal lining, most commonly 4th ventricleExtent of surgical resection is a critical prognostic determinant; often adherent to ventricular floor/brainstem, making complete resection challenging

Red Flag Signs of Raised Intracranial Pressure

  • Early morning headache (improves through the day)
  • Vomiting (especially without other GI symptoms; relieves headache)
  • Papilledema on fundoscopy
  • Cranial nerve palsies (especially VI nerve — a “false localizing sign” given its long intracranial course)
  • Ataxia/gait disturbance (reflecting posterior fossa predominance)
  • In infants: increasing head circumference, bulging anterior fontanelle

Any combination warrants prompt neuroimaging — general raised ICP recognition/management principles (Section 2, Q29) apply equally here.

lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 184 person Asked by .
bookmark_add

Kawasaki Disease (KD) & Coronary Aneurysms

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q141 ★ · DNB/MD 2025/1
Kawasaki Disease (KD) & Coronary Aneurysms
Examiner's Intent: KD is a near-universal, guaranteed high-yield topic given both its clinical importance and its direct comparative relationship to MIS-C (Section 3, Q47) — examiners expect precise AHA diagnostic criteria (complete versus incomplete), a clear understanding of the echocardiographic coronary surveillance schedule, and knowledge of the IVIG-resistance management escalation pathway.

AHA Guidelines — Complete Kawasaki Disease

Diagnosed based on fever for ≥5 days combined with at least 4 of the following 5 principal clinical features:

#FeatureDetails
1Bilateral, non-exudative conjunctival injection
2Oral mucosal changesErythematous, cracked lips; “strawberry tongue” (prominent erythematous papillae); diffuse oral/pharyngeal erythema
3Polymorphous rashVariable in morphology, typically truncal
4Extremity changesAcute: erythema/edema of hands and feet. Subacute (2–3 weeks): periungual desquamation — a useful retrospective clue
5Cervical lymphadenopathyTypically unilateral, ≥1 node ≥1.5 cm — the least consistently present feature

Incomplete Kawasaki Disease

In a child with fever ≥5 days and only 2–3 principal criteria (particularly relevant in infants, who carry disproportionately elevated coronary complication risk), the AHA algorithm incorporates:

  • Supplemental laboratory criteria — elevated CRP/ESR plus supportive findings: anemia, thrombocytosis after day 7, hypoalbuminemia, elevated ALT, leukocytosis, sterile pyuria
  • Echocardiographic findings — coronary artery abnormalities are themselves sufficient supportive evidence to diagnose incomplete KD and initiate treatment

[Diagram: AHA incomplete-KD algorithm flowchart: fever ≥5 days + 2-3 criteria → CRP/ESR → supplemental labs / echo → diagnosis pathway]

Echocardiographic Screening for Coronary Artery Aneurysms

TimingPurpose
At diagnosisBaseline assessment
~1–2 weeks after treatment initiationEarly surveillance
~4–6 weeks after illness onsetLater surveillance (extended further if coronary abnormalities confirmed)

Coronary findings are graded using standardized z-score-based (body-surface-area-adjusted) classification: no involvement → small → medium → large/giant aneurysm — directly determining follow-up intensity and antithrombotic strategy.

IVIG Resistance and Escalation Therapy

Standard initial treatment: IVIG 2 g/kg single infusion + aspirin.

  1. Second dose of IVIG (2 g/kg) — first escalation step for IVIG-resistant disease
  2. Methylprednisolone/corticosteroids — escalation step, or upfront in high-risk children (validated risk-scoring systems)
  3. Infliximab (anti-TNF-alpha) — for refractory disease despite IVIG + steroid escalation

Long-Term Management

Stratified by aneurysm size: low-dose aspirin alone for small aneurysms → combined antiplatelet + anticoagulant therapy for large/giant aneurysms (elevated thrombosis risk), with periodic cardiology follow-up, stress testing, and consideration of interventional/surgical revascularization for significant coronary stenosis.

lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 185 person Asked by .
bookmark_add

Tetralogy of Fallot (TOF) & Hypercyanotic Spells

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q142 ★ · DNB/MD 2024/2
Tetralogy of Fallot (TOF) & Hypercyanotic Spells
Examiner's Intent: TOF represents the prototype cyanotic congenital heart lesion; examiners expect the four anatomical components reproduced precisely with clear pathophysiological linkage, along with the specific, stepwise emergency management sequence for a hypercyanotic (“tet”) spell.

Anatomical Components — The Classic Tetrad

  1. Ventricular Septal Defect (VSD) — typically large, non-restrictive, perimembranous
  2. Right Ventricular Outflow Tract (RVOT) obstruction (pulmonary stenosis) — the primary determinant of clinical severity/cyanosis, ranging from mild infundibular narrowing to complete pulmonary atresia
  3. Overriding aorta — aortic root positioned overriding the VSD, receiving flow from both ventricles
  4. Right ventricular hypertrophy — secondary, compensatory (not a primary defect)

[Diagram: Cross-sectional schematic of TOF heart showing VSD, overriding aorta, RVOT obstruction, and RV hypertrophy]

Pathophysiology

Degree of RVOT obstruction determines shunt direction/magnitude across the VSD — more severe obstruction → greater right-to-left shunting → desaturated blood enters systemic circulation → cyanosis.

Pathophysiology of Hypercyanotic (“Tet”) Spells

Acute worsening of right-to-left shunting triggered by:

Trigger MechanismExamples
Increased RVOT obstructionInfundibular spasm from crying, agitation, feeding, defecation (↑ catecholamines)
Decreased systemic vascular resistanceWarm bath, fever, vasodilation on waking from sleep
Note: Resulting hypoxemia triggers further catecholamine release/hyperventilation → worsens infundibular spasm → a self-perpetuating cycle if not promptly interrupted.

Acute Emergency Management — Stepwise Sequence

  1. Knee-to-chest positioning (infants) or squatting (older children) — ↑ SVR by mechanically compressing femoral arteries/↑ afterload → reduces R-to-L shunt gradient — single most important first step
  2. Calm the child — minimizes catecholamine-driven infundibular spasm
  3. Oxygen — limited benefit (fixed anatomical shunt) but reasonable, low-risk adjunct
  4. Morphine — sedation + direct relaxant effect on infundibular musculature
  5. IV fluid bolus — ↑ preload/circulating volume, improves forward flow across obstructed RVOT
  6. Phenylephrine (pure alpha-agonist) — pharmacologically ↑ SVR
  7. Beta-blockade (propranolol/esmolol) — directly reduces dynamic infundibular spasm
  8. General anesthesia and emergency surgery — final escalation for refractory spells
Critical: Agents that increase pulmonary vascular resistance or decrease systemic vascular resistance (worsening R-to-L shunt) must be specifically avoided during a tet spell.

Palliative Shunts and Definitive Repair

ProcedureDescription
Modified Blalock-Taussig (BT) ShuntSynthetic graft connecting subclavian artery to pulmonary artery — palliative bridge for symptomatic infants not yet suitable for complete repair
Definitive surgical repairVSD closure (patch) + relief of RVOT obstruction (infundibular muscle resection and/or transannular patch) — increasingly performed as primary complete repair in early infancy
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 186 person Asked by .
bookmark_add

Ventricular Septal Defect (VSD) & Eisenmenger Syndrome

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q143 · DNB/MD 2024/1
Ventricular Septal Defect (VSD) & Eisenmenger Syndrome
Examiner's Intent: Expects the size/PVR-dependent hemodynamic framework for VSD, the progression pathway to irreversible pulmonary hypertension (Eisenmenger physiology), and the resulting critical treatment implications once this irreversible stage is reached.

Hemodynamics — Size and Pulmonary Vascular Resistance (PVR)

VSD TypeDeterminant of FlowClinical Consequence
Small (restrictive)The defect itself limits flowLoud, high-pitched murmur; minimal hemodynamic consequence
Large (non-restrictive)Relative PVR vs SVR determines shunt volume/directionPredominant left-to-right shunt initially (PVR normally < SVR) → pulmonary overcirculation → heart failure (poor feeding, FTT, tachypnea) if uncorrected

Development of Pulmonary Arterial Hypertension and Eisenmenger Physiology

Chronic exposure to elevated flow/pressure → progressive pulmonary vascular remodeling: initially reversible functional changes → if uncorrected, irreversible structural changes (medial hypertrophy, intimal fibrosis, plexiform lesions) → rising PVR.


[Diagram: Progression diagram: normal pulmonary arteriole → medial hypertrophy → intimal fibrosis → plexiform lesion, with PVR rising and shunt reversing]

Once PVR approaches/exceeds SVR, shunt direction reverses (right-to-left or bidirectional) — this fixed pulmonary hypertension + shunt reversal + cyanosis = Eisenmenger syndrome.

Critical: Once true Eisenmenger physiology has developed, surgical closure of the VSD is CONTRAINDICATED — closure eliminates the “pop-off” pathway for the hypertensive, remodeled right ventricle, precipitating acute severe right heart failure and death.

Indications for Intervention versus Medical Management

VSD CategoryManagement
Small, hemodynamically insignificantObservation alone — many close spontaneously in infancy/early childhood
Large, hemodynamically significant with symptomatic overcirculationSurgical (or selected transcatheter device) closure, generally in infancy, before irreversible pulmonary vascular remodeling develops

Medical management (diuretics, heart-failure-directed therapy) may bridge infants awaiting surgery or optimize clinical status pre-operatively.

lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 187 person Asked by .
bookmark_add

Coarctation of the Aorta (CoA)

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q144 ★ · DNB/MD 2023/2
Coarctation of the Aorta (CoA)
Examiner's Intent: CoA is a favorite topic because it presents so differently depending on age at presentation; examiners expect articulation of why the neonatal presentation is a genuine emergency requiring immediate PGE1 — building on ductal physiology from Section 1, Q22.

Clinical Presentation — An Age-Dependent Spectrum

Age GroupPresentation
Neonate (severe CoA)“Ductal-dependent” lower-body perfusion. As the ductus closes (first 24–48h), lower-body perfusion is progressively compromised → poor feeding, lethargy, differential cyanosis, diminished/absent femoral pulses, severe metabolic acidosis, multi-organ hypoperfusion — a genuine cardiovascular emergency
Older child (milder CoA)Upper extremity hypertension + classic radio-femoral pulse delay (delayed/diminished femoral pulse relative to radial pulse) — a key exam finding prompting evaluation for coarctation in pediatric hypertension

Imaging

Echocardiography — first-line, visualizes the coarcted segment and associated abnormalities (bicuspid aortic valve is the most common association; severe cases may show hypoplastic left heart structures). CT/MR angiography — detailed anatomical characterization for surgical/interventional planning or complex/older cases.

Prostaglandin E1 (PGE1) Infusion — The Critical Emergency Intervention

Critical: For the neonate with severe, ductal-dependent coarctation and cardiogenic shock, immediate PGE1 infusion is the single most critical, life-saving intervention — maintains/re-opens ductal patency, restoring lower-body perfusion and reversing shock.

PGE1 side effects requiring monitoring: apnea (careful respiratory monitoring, often prophylactic intubation readiness during transport), fever, peripheral vasodilation/hypotension.

Surgical and Catheter-Based Interventions

ApproachNotes
Surgical repairResection of coarcted segment with end-to-end anastomosis (or other reconstruction) — traditional, definitive; favored for neonates/infants
Balloon angioplasty ± stentTranscatheter alternative, especially for recurrent coarctation post-surgery; may be primary treatment in selected older children/adolescents
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 188 person Asked by .
bookmark_add

Transposition of the Great Arteries (TGA)

description Clinical Response
Q145 ★ · DNB/MD 2023/1
Transposition of the Great Arteries (TGA)
Examiner's Intent: TGA is the prototype cyanotic lesion where survival paradoxically depends on maintaining, rather than closing, communications between parallel circulations. Examiners expect clear articulation of the “parallel circulation” concept, the emergency intervention (balloon atrial septostomy), and the definitive surgery.

Pathophysiology — The “Parallel Circulation” Problem

In d-TGA, the aorta arises from the RV and the pulmonary artery arises from the LV (ventriculoarterial discordance), creating two parallel circulations instead of the normal serial arrangement:


[Diagram: Parallel circulation schematic: systemic venous blood → RA → RV → aorta → body (no lung passage); pulmonary venous blood → LA → LV → PA → lungs (no systemic passage)]
Note: Without a point of communication/mixing between the two circuits, TGA is fundamentally incompatible with survival regardless of other defect severity — management is entirely focused on ensuring/creating mixing, in sharp contrast to most other cyanotic lesions where the goal is to reduce shunting.

Neonatal Presentation

Severe cyanosis from birth, often with relatively preserved respiratory effort initially. Severity/timing of cyanosis depends on natural intercirculatory mixing (foramen ovale, VSD if present, ductus arteriosus). Most severe/earliest cyanosis in “simple” TGA (intact ventricular septum).

Balloon Atrial Septostomy (Rashkind Procedure)

Emergency, life-saving palliative catheter intervention for inadequate intercirculatory mixing despite PGE1: a balloon-tipped catheter is advanced across the foramen ovale into the LA, then rapidly withdrawn while inflated, tearing/enlarging the atrial septal opening — creating a larger, non-restrictive interatrial communication and dramatically improving mixing.

Adjunctive PGE1 Infusion

Maintains ductal patency as an additional mixing site — may be sufficient alone in some cases without septostomy, if ductal-level mixing is adequate.

Arterial Switch Operation (Jatene Procedure)

Definitive, curative repair: transects and switches the aorta and pulmonary artery to their correct ventricular origins, plus coronary artery transfer/reimplantation to the neo-aortic root — the most technically challenging step given small neonatal coronary caliber.

Note: Performed within the first 2–3 weeks of life — the LV (pulmonary-pressure ventricle in utero) must be surgically corrected before it “de-conditions” and becomes inadequately prepared to assume the higher-pressure systemic workload.
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 189 person Asked by .
bookmark_add

Pediatric Arrhythmias: SVT & AV Block

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q146 · DNB/MD 2022/2
Pediatric Arrhythmias: SVT & AV Block
Examiner's Intent: Expects the characteristic ECG features distinguishing SVT from sinus tachycardia, the stepwise management algorithm (vagal maneuvers through cardioversion), and awareness of congenital complete heart block as a distinct entity.

Diagnostic ECG Features of SVT (vs. Sinus Tachycardia)

FeatureSVTSinus Tachycardia
QRSNarrow (usual)Narrow
RateVery rapid, regular; often >220 bpm (infants), >180–200 bpm (older children)Elevated but within physiologically expected range
P wavesOften absent, abnormal morphology/axis, or buried in preceding T wave (retrograde activation)Normal, upright, precedes each QRS
Onset/termination and rate variabilityAbrupt onset/termination; fixed, unwavering rateGradual rate changes reflecting underlying physiological drivers (fever, agitation)

Management — Stepwise Algorithm

  1. Vagal maneuvers — ice pack/cold stimulus to face in infants (diving reflex); Valsalva or carotid sinus massage in older children
  2. Adenosine — rapid IV push + immediate rapid saline flush (very short half-life); transiently blocks AV nodal conduction — diagnostic and therapeutic
  3. Synchronized cardioversion — for hemodynamically unstable SVT, or stable SVT refractory to adenosine
  4. Chronic prophylaxis — antiarrhythmic medication or catheter ablation (potentially curative) for recurrent, symptomatic episodes

[Diagram: ECG strip comparison: SVT (narrow QRS, absent/retrograde P waves, very rapid regular rate) vs sinus tachycardia (normal P before each QRS)]

Congenital Complete Heart Block

Distinct from acquired conduction disease — most commonly due to transplacental transfer of maternal anti-Ro/SSA and anti-La/SSB antibodies (mothers with, or later found to have, SLE or Sjögren syndrome). Causes immune-mediated injury to the fetal conduction system → complete (third-degree) AV block, identified antenatally (fetal bradycardia on echo) or at birth.

Note: Symptomatic congenital complete heart block (slow escape rhythm, hemodynamic compromise, associated cardiac dysfunction) requires permanent pacemaker implantation.
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 190 person Asked by .
bookmark_add

Rheumatic Heart Disease (RHD) & Mitral Stenosis

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
Q147 · DNB/MD 2022/1
Rheumatic Heart Disease (RHD) & Mitral Stenosis
Examiner's Intent: Expects understanding of the chronic valvular pathology resulting from recurrent rheumatic carditis, clinical evaluation of the resulting valvular lesions, and clear secondary prophylaxis duration guidance building on the Jones Criteria/ARF discussion in Section 3, Q64.

Pathology of Chronic RHD

Cumulative valvular consequence of recurrent (or occasionally single severe) rheumatic carditis episodes — progressive fibrosis, thickening, calcification, and fusion of valve leaflets and subvalvular apparatus (chordae tendineae, papillary muscles). The mitral valve is most commonly/severely affected, followed by the aortic valve. Early disease favors regurgitation; advanced disease favors stenosis.

Clinical Evaluation of Mitral Regurgitation and Stenosis

LesionTimingAuscultatory FindingsOther Features
Mitral RegurgitationEarlier, often soon after acute carditisPansystolic murmur at the apex, radiating to axillaLA ± LV volume overload
Mitral StenosisLater, reflects advanced fibrotic/calcific remodelingLow-pitched mid-diastolic murmur (apex, left lateral position), opening snap, loud S1 (early stage)Dyspnea especially with exertion/pregnancy/fever (↓ diastolic filling time); pulmonary HTN and right heart involvement in advanced disease

Echocardiographic Scoring

Standardized scoring (leaflet mobility, thickening, calcification, subvalvular involvement) grades severity and assesses suitability for balloon mitral valvuloplasty (preferred for pliable, minimally calcified valves) versus surgical valve replacement (greater long-term complications given young patient age — lifelong anticoagulation, valve degeneration).

Secondary Penicillin Prophylaxis Guidelines

Note: Patients with established, persistent rheumatic valvular heart disease require lifelong secondary prophylaxis — Benzathine Penicillin G every 3–4 weeks (3-weekly interval favored in higher-risk settings/patients) — extending the general ARF secondary prophylaxis framework (Q64) to this highest-risk category.

Showing 181190 of 271 questions

account_tree

Subcategory Tree

Explore Pediatrics subcategories

folder_special Pediatrics
Main
lock

Category Subscription

Subscribe to Pediatrics to unlock this module and all nested subcategories.

  • check_circle Access Pediatrics & all subcategories
  • check_circle Detailed, Peer-Reviewed Answers
  • check_circle High-yield visual aids & imaging
Get Category Subscription arrow_forward
Secure 256-bit SSL Connection

Anatomical Models

Explore high-fidelity 3D visualizations included in premium modules.

Case Reviews

Real-world clinical scenarios narrated by senior consultants.

Pulse App